Application of AI in urolithiasis risk of infection: a scoping review.


Journal

Minerva urology and nephrology
ISSN: 2724-6442
Titre abrégé: Minerva Urol Nephrol
Pays: Italy
ID NLM: 101777299

Informations de publication

Date de publication:
Jun 2024
Historique:
medline: 26 6 2024
pubmed: 26 6 2024
entrez: 26 6 2024
Statut: ppublish

Résumé

Artificial intelligence and machine learning are the new frontier in urology; they can assist the diagnostic work-up and in prognostication bring superior to the existing nomograms. Infectious events and in particular the septic risk, are one of the most common and in some cases life threatening complication in patients with urolithiasis. We performed a scoping review to provide an overview of the current application of AI in prediction the infectious complications in patients affected by urolithiasis. A systematic scoping review of the literature was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses for Scoping Reviews (PRISMA-ScR) guidelines by screening Medline, PubMed, and Embase to detect pertinent studies. A total of 467 articles were found, of which nine met the inclusion criteria and were considered. All studies are retrospective and published between 2021 and 2023. Only two studies performed an external validation of the described models. The main event considered is urosepsis in four articles, urinary tract infection in two articles and diagnosis of infection stones in three articles. Different AI models were trained, each of which exploited several types and numbers of variables. All studies reveal good performance. Random forest and artificial neural networks seem to have higher AUC, specificity and sensibility and perform better than the traditional statistical analysis. Further prospective and multi-institutional studies with external validation are needed to better clarify which variables and AI models should be integrated in our clinical practice to predict infectious events.

Identifiants

pubmed: 38920010
pii: S2724-6051.24.05686-6
doi: 10.23736/S2724-6051.24.05686-6
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

295-302

Auteurs

Davide Campobasso (D)

Urology Unit, University Hospital of Parma, Parma, Italy - d.campobasso@virgilio.it.

Matteo Panizzi (M)

Anesthesiology, Critical Care and Pain Medicine Division, Department of Medicine and Surgery, University of Parma, Parma, Italy.

Valentina Bellini (V)

Anesthesiology, Critical Care and Pain Medicine Division, Department of Medicine and Surgery, University of Parma, Parma, Italy.

Stefania Ferretti (S)

Department of Urology, University of Modena e Reggio Emilia, Modena, Italy.

Daniele Amparore (D)

Division of Urology, Department of Oncology, School of Medicine, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy.

Daniele Castellani (D)

Department of Urology, Azienda Ospedaliera Universitaria delle Marche, Università Politecnica delle Marche, Ancona, Italy.

Cristian Fiori (C)

Division of Urology, Department of Oncology, School of Medicine, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy.

Stefano Puliatti (S)

Department of Urology, University of Modena e Reggio Emilia, Modena, Italy.

Amelia Pietropaolo (A)

Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Bhaskar K Somani (BK)

Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Salvatore Micali (S)

Department of Urology, University of Modena e Reggio Emilia, Modena, Italy.

Francesco Porpiglia (F)

Division of Urology, Department of Oncology, School of Medicine, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy.

Umberto V Maestroni (UV)

Urology Unit, University Hospital of Parma, Parma, Italy.

Elena G Bignami (EG)

Anesthesiology, Critical Care and Pain Medicine Division, Department of Medicine and Surgery, University of Parma, Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH